Everyday Health on MSN
IVIg to SCIg: Considerations when switching immunoglobulin therapies for primary immunodeficiency
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, costs, and how each impacts quality of life.
After encapsulated cells secrete human IgG, the fluorescent probes attach to the protein. The combination of Cyto-Cellect ® PLUS and Cyto-Mine ® provides a test for measuring single-cell productivity ...
Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial evaluating ...
TEANECK, N.J., June 27, 2025 /PRNewswire/ -- GC Biopharma USA, Inc., a leader in plasma-derived products, announced the presentation of data at the 2025 Clinical Immunology Society (CIS) Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results